Cardiometabolic Effects of Anti-obesity Pharmacotherapy.

Abstract

PURPOSE OF REVIEW We review recent studies discussing the impact of pharmacologic agents for weight loss on clinical cardiovascular events, as well as cardiometabolic risk factors. RECENT FINDINGS Pharmacotherapy with current FDA-approved medications for weight loss can significantly improve known risk factors for the development of cardiovascular disease… (More)
DOI: 10.1007/s11883-018-0719-9

Topics

  • Presentations referencing similar topics